1. Home
  2. AIRT vs BDSX Comparison

AIRT vs BDSX Comparison

Compare AIRT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air T Inc.

AIRT

Air T Inc.

HOLD

Current Price

$23.50

Market Cap

60.5M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$17.25

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRT
BDSX
Founded
1980
2005
Country
United States
United States
Employees
646
N/A
Industry
Air Freight/Delivery Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.5M
122.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AIRT
BDSX
Price
$23.50
$17.25
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
2.3K
145.0K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$23.35
Revenue Next Year
N/A
$19.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$14.56
$0.25
52 Week High
$26.70
$20.21

Technical Indicators

Market Signals
Indicator
AIRT
BDSX
Relative Strength Index (RSI) 61.36 62.15
Support Level $20.81 $6.33
Resistance Level $23.94 N/A
Average True Range (ATR) 0.67 1.86
MACD 0.03 0.08
Stochastic Oscillator 85.91 64.40

Price Performance

Historical Comparison
AIRT
BDSX

About AIRT Air T Inc.

Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: